GGrantIndex
Sort

10,829 grants matching car t

Amplifying and Redirecting CMV-specific CD8 T cells to provide sustained control of HIV infection

$839,997
Harris Goldstein · Albert Einstein College Of Medicine · R01 · FY2023 · AI

2/2 Sickle Cell Disease and CardiovAscular Risk - Red cell Exchange Trial (SCD-CARRE Trial)

$838,879
Maria Mori Brooks · University Of Pittsburgh At Pittsburgh · U24 · FY2021 · HL

Advancing treatment and understanding of immunotherapy in glioblastoma

$838,812
Nicholas A Butowski · University Of California, San Francisco · U19 · FY2025 · CA

HIV Reprogrammed Airway Basal Cells Acquire a “Tissue Destructive” Phenotype

$838,744
Ronald G Crystal · Weill Medical Coll Of Cornell Univ · R01 · FY2019 · HL

HIV Reprogrammed Airway Basal Cells Acquire a “Tissue Destructive” Phenotype

$838,744
Ronald G Crystal · Weill Medical Coll Of Cornell Univ · R01 · FY2018 · HL

HIV Reprogrammed Airway Basal Cells Acquire a “Tissue Destructive” Phenotype

$838,744
Ronald G Crystal · Weill Medical Coll Of Cornell Univ · R01 · FY2016 · HL

Technology-Enabled Activation of Skin Cancer Screening for Hematopoietic Cell Transplantation Survivors and their Primary Care Providers

$838,645
Saro Armenian · Beckman Research Institute/City Of Hope · R01 · FY2021 · CA

Socializing a Science-based Digital Therapeutic for Substance Use Disorders

$836,571
Michael John Grabinski · Square2 Systems, Inc. · R44 · FY2021 · DA

Project 1: Greenspace to build resilience to climate change impacts on health: The good, the bad, and the future

$835,967
Shujuan Li · University Of Arizona · P20 · FY2023 · ES

Autologous T-cells Expressing a Chimeric Antigen Receptor Directed to B-Cell Maturation Antigen (BCMA) in patients with Generalized Myasthenia Gravis (MG)

$835,858
Metin Kurtoglu · Cartesian Therapeutics, Inc. · R44 · FY2020 · NS

International Brotherhood of Teamsters Hazmat Training on DOE Weapons Complexes

$834,778
Lamont Byrd · International Brotherhood Of Teamsters · UH4 · FY2019 · ES

International Brotherhood of Teamsters Hazmat Training on DOE Weapons Complexes

$834,776
Lamont Byrd · International Brotherhood Of Teamsters · UH4 · FY2018 · ES

Theranostic CAR-T Targeting Senescence in Alzheimer's

$834,627
Lina Cui · University Of Florida · R61 · FY2025 · AG

HIV Reprogrammed Airway Basal Cells Acquire a “Tissue Destructive” Phenotype

$834,313
Ronald G Crystal · Weill Medical Coll Of Cornell Univ · R01 · FY2017 · HL

Comprehensive Interrogation of Toxicity Profiles Associated with Novel CAR T-cell Constructs

$834,260
Nirali Shah · Division Of Basic Sciences - Nci · ZIA · FY2025 · CA

Development of Novel Approaches to Optimize CAR T-cell Therapies for B-cell Malignancies

$834,260
Nirali Shah · Division Of Basic Sciences - Nci · ZIA · FY2025 · CA

In vivo transformation of chimeric antigen receptor B cells for a functional cure of HIV

$833,420
Michael R. Farzan · Boston Children'S Hospital · R01 · FY2025 · AI

STI: Flexible Wireless Systems for Rapid Network Evolution

$832,500
Gary J Minden · University Of Kansas Center For Research Inc · · FY2003 · CSE

Pediatric Oncology Branch Behavioral Science Core

$832,046
John Glod · Division Of Basic Sciences - Nci · ZID · FY2020 · CA

Smart driving technology for non-invasive detection of age-related cognitive decline

$831,790
Francis Tsow · Tf Health Corporation · R44 · FY2025 · AG

LTBR CARs as next-generation therapies for R/R lymphoma

$831,692
Neville Sanjana · New York Genome Center · R01 · FY2023 · CA

Interactive Parent-targeted Text Messaging in Pediatric Clinics to Reduce ECC

$831,634
Belinda Borrelli · Boston University Medical Campus · UH3 · FY2021 · DE

CAREER: Human/Machine Collaborative Learning and Control of Contact-Rich Dynamics

$830,690
Sam Burden · University Of Washington · · FY2021 · ENG

Role of Glycosphingolipids in Kidney Disease in Diabetes and Obesity

$830,500
Moshe Levi · Georgetown University · R01 · FY2025 · DK

Targeting HIV-specific T cell differentiation programs to enhance post-treatment control of HIV

$829,262
Rachel Lena Rutishauser · University Of California, San Francisco · R01 · FY2024 · AI